• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthMonsanto

Monsanto is Giving Cash to U.S. Farmers to Use its Controversial Weedkiller

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
December 11, 2017, 4:48 AM ET

Monsanto (MON) will give cash back to U.S. farmers who buy a weedkiller that has been linked to widespread crop damage, offering an incentive to use its product even as regulators in several U.S. states weigh restrictions on its use.

The incentive to use XtendiMax with VaporGrip, a herbicide based on a chemical known as dicamba, could refund farmers over half the sticker price of the product in 2018 if they spray it on soybeans that Monsanto engineered to resist it, according to company data.

The United States faced an agricultural crisis this year caused by new formulations of dicamba-based herbicides, which farmers and weed experts say harmed crops because they evaporated and drifted away from where they were sprayed.

Read: Monsanto Has Postponed Launching a New Chemical After Reports That It Causes Rashes

Monsanto says XtendiMax is safe when properly applied. The company is banking on the chemical and soybean seeds engineered to resist it, called Xtend, to dominate soybean production in the U.S., the world’s second-largest exporter.

Germany’s BASF and DowDuPont also sell versions of dicamba-based herbicides.

Monsanto’s cash-back offer comes as federal and state regulators are requiring training for farmers who plan to spray dicamba in 2018 and limiting when it can be used. Weed specialists say the restrictions make the chemical more costly and inconvenient to apply, but Monsanto’s incentive could help convince farmers to use it anyway.

“We believe cash-back incentives for using XtendiMax with VaporGrip Technology better enable growers to use a management system that represents the next level of weed control,” said Ryan Rubischko, Monsanto product manager.

XtendiMax costs about $11 per acre to buy, and Monsanto is offering $6 per acre in cash back to farmers when they apply it on Xtend soybeans along with other approved herbicides, according to the company.

Currently, Monsanto competes against rivals including Bayer to sell genetically modified soybean seeds and chemicals to farmers. Bayer is selling its LibertyLink soybean brand, a main rival to Xtend, to BASF as part of a deal to acquire Monsanto for $63.5 billion.

Monsanto also faces increasing government oversight.

This month, North Dakota said it planned to prohibit the use of dicamba herbicides after June 30, 2018, and when temperatures top 85 degrees Fahrenheit, in a bid to prevent the chemical from drifting away from where it is sprayed.

Read: U.S. Scientists to Skip Monsanto Summit on Controversial Weed Killer

Missouri said it intends to finalize restrictions on XtendiMax soon, after banning sprayings of BASF’s dicamba herbicide, called Engenia, in 10 counties after June 1, 2018, and statewide after July 15, 2018.

Arkansas is close to prohibiting dicamba sprayings after April 15, 2018, the tightest limits yet, while Minnesota is also considering restrictions.

The states are taking action after the U.S. Environmental Protection Agency mandated special training for dicamba users for 2018, requiring farmers to keep records proving they were complying with label instructions.

“Utilizing the technology, the cost will go up because of these changes,” said Andrew Thostenson, a pesticide specialist for North Dakota State University.

Monsanto predicts U.S. farmers will double plantings of Xtend soybeans to about 40 million acres next year despite reports of crop damage this past summer.

Farmers said its cash-back offer was designed to increase sales.

“I think they’re just trying to buy more acres,” Dan Henebry, an Illinois farmer who plans to grow Xtend soybeans next year, said about Monsanto.

About the Author
By Reuters
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

SuccessOlympics
U.S. Olympians earn just 5% of what Singapore pays—many are forced to juggle jobs as baristas, brokers, and dentists just to get by
By Sydney LakeFebruary 10, 2026
1 day ago
oz
PoliticsVaccines
Dr. Oz pleads with America: ‘take the vaccine, please’ as measles soar on RFK-led revival
By Matt Brown and The Associated PressFebruary 10, 2026
1 day ago
AIOpenAI
Panicked about losing GPT-4o, some ChatGPT users are building DIY versions. A psychologist explains why ‘feel-good hormones’ make it hard to let go
By Marco Quiroz-GutierrezFebruary 10, 2026
1 day ago
tara comonte
CommentaryAdvertising
Weight Watchers CEO: what the GLP-1 Super Bowl ads are missing
By Tara ComonteFebruary 9, 2026
2 days ago
CommentaryHealth
Patient private capital is needed to help Asia plug its healthcare gaps
By Abrar MirFebruary 8, 2026
3 days ago
Arts & EntertainmentAdvertising
Super Bowl ads go for silliness, tears and nostalgia as Americans reel from ‘collective trauma’ of recent upheaval — ‘Everybody is stressed out’
By Dee-Ann Durbin, Mae Anderson, Wyatte Grantham-Philips and The Associated PressFebruary 8, 2026
3 days ago

Most Popular

placeholder alt text
Economy
America borrowed $43.5 billion a week in the first four months of the fiscal year, with debt interest on track to be over $1 trillion for 2026
By Eleanor PringleFebruary 10, 2026
1 day ago
placeholder alt text
Economy
It turns out that Joe Biden really did crush Americans' dreams for the future. Just look at how the vibe changed 5 years ago
By Jake AngeloFebruary 10, 2026
22 hours ago
placeholder alt text
C-Suite
Meet Jody Allen, the billionaire owner of the Seattle Seahawks, who plans to sell the team and donate the proceeds to charity
By Jake AngeloFebruary 9, 2026
2 days ago
placeholder alt text
AI
As billionaires bail, Mark Zuckerberg doubles down on California with $50 million donation
By Sydney LakeFebruary 9, 2026
2 days ago
placeholder alt text
Economy
China might be beginning to back away from U.S. debt as investors get nervous about overexposure to American assets
By Eleanor PringleFebruary 9, 2026
2 days ago
placeholder alt text
C-Suite
'Don't look at the résumé': Elon Musk admits he's 'fallen prey' to flashy credentials but says conversation matters most when hiring
By Jacqueline MunisFebruary 9, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.